First regulatory qualification of a digital primary endpoint to measure treatment efficacy in DMD

Nat Med. 2023 Oct;29(10):2391-2392. doi: 10.1038/s41591-023-02459-5.
No abstract available

Publication types

  • Letter

MeSH terms

  • Humans
  • Muscular Dystrophy, Duchenne* / drug therapy
  • Muscular Dystrophy, Duchenne* / genetics
  • Treatment Outcome